Guilin Layn Natural Ingredients Corp.: history, ownership, mission, how it works & makes money

From its founding in Guilin in 1995 to becoming the first publicly listed Chinese botanical-extract firm on the Shenzhen Stock Exchange (002166.SZ) in 2002, Guilin Layn Natural Ingredients has grown into a vertically integrated global supplier-expanding manufacturing in 2000 to offer over 80 botanical extracts, building more than 2.2 million sq ft of extraction and innovation capacity, and broadening reach with regional operations in the USA, Europe and Latin America; ownership remains anchored with co-founders Jiang and Yao and a diversified public shareholder base, while strategic moves such as the 51% acquisition of Chengdu Wagott in 2020, a planned $148 million investment in 2021, and the launch of poultry and swine feed additives at IPPE in 2025 illustrate its mission-driven focus on high-purity stevia, monk fruit, tea extract and other solutions across food, nutraceutical, pharmaceutical, personal care and animal nutrition markets-a strategy that helped drive CNY 1.77 billion in revenue in 2024 (up 18.60% YoY) and underpins analyst forecasts of CNY 2.48 billion in 2025 and CNY 2.996 billion in 2026, reflecting how integrated supply, branded solutions and R&D convert plant-based ingredients into diversified, growing revenue streams.

Guilin Layn Natural Ingredients Corp. (002166.SZ): Intro

• Founded: 1995 in Guilin, Guangxi Province.
• Public listing: First botanical-extract company listed on the Shenzhen Stock Exchange (2002).
• Product breadth: Expanded manufacturing to offer over 80 botanical extracts by 2000.
• Strategic acquisition: 51% stake in Chengdu Wagott Bio‑tech Co., Ltd. (2020), strengthening green tea extract export capabilities.
• Major investment plan: Announced a $148 million expansion program in 2021 for infrastructure, innovation and supply-chain security.
• New products: Launched poultry and swine feed additives at IPPE (2025), entering specialty animal-nutrition offerings.

• Listed entity ticker: 002166.SZ (Shenzhen Stock Exchange).
• Major holdings: corporate ownership traditionally combines founding shareholders, institutional investors and public float; strategic acquisitions (e.g., 51% Chengdu Wagott) expand product-control and export capability.
• Governance: Board-led public company structure with audit and R&D oversight to support regulatory compliance and export markets.

• Mission: Develop and supply high-quality natural ingredients that support human and animal health, leveraging botanical science and scaled manufacturing.
• Strategic pillars:
  • Product diversification - move from botanical extracts into nutraceuticals, cosmetics actives and animal‑nutrition additives.
  • Vertical integration - control from raw plant sourcing through extraction to finished product to improve margin and supply security.
  • Global distribution - expand export channels and partnerships, exemplified by the Chengdu Wagott acquisition.

• Raw material sourcing: Partnerships with growers and in-house cultivation in key botanical regions to ensure quality and traceability.
• Extraction & processing: Multi-technology extraction (solvent, water, ethanol, supercritical CO2 where applicable), purification and standardization to meet customer specifications.
• R&D & quality control: Analytical chemistry, bioactivity screening and formulation support to develop standardized extracts and new ingredient forms.
• Manufacturing scale-up: Facilities scaled to produce metric-ton quantities of standardized ingredients for industrial buyers.
• Sales & distribution: Direct sales to ingredient formulators and branded manufacturers plus export channels to global markets.

• Ingredient sales: Primary revenue from bulk botanical extracts (e.g., tea catechins, ginsenosides, flavonoids) sold to food, supplement, pharmaceutical and cosmetic manufacturers.
• Value-added products: Formulated nutraceuticals, standardized actives and finished premixes for animal feed generate higher-margin sales as the company moves downstream.
• Contract manufacturing & custom development: Fees and margin from toll-processing, private-label production and R&D partnerships.
• Export & licensing: Income from international distribution agreements and technology licensing tied to proprietary extraction or standardization methods.

• Product portfolio: More than 80 botanical extracts (established by 2000) covering tea extracts, ginkgo, ginseng, hawthorn, citrus bioflavonoids and specialty polyphenols.
• Supply-chain security: 2021's $148 million program directed at capacity expansion and innovation to serve global demand and reduce single-source risk.
• Animal nutrition entry: 2025 IPPE launch of poultry and swine feed additives positions the company to capture demand for natural growth promoters and health-supporting additives in livestock.

• Product mix by revenue: bulk extracts vs. value-added formulations and animal-nutrition products.
• Gross margin trends: influenced by raw-material costs, extraction yields and downstream value capture.
• Capital expenditure: progress and deployment of the $148 million expansion plan (2021 announcement).
• M&A and partnership activity: e.g., integration and export gains from Chengdu Wagott (51% stake acquired 2020).

Guilin Layn Natural Ingredients Corp. (002166.SZ): History

• Founded by Mr. Jiang and Mr. Yao, Guilin Layn Natural Ingredients Corp. (002166.SZ) grew from a regional botanical-extracts supplier into a nationally listed nutraceutical and natural-ingredients producer.
• The company is publicly traded on the Shenzhen Stock Exchange under ticker 002166.SZ.
• In 2020 Layn acquired a 51% stake in Chengdu Wagott Bio-tech Co., Ltd., integrating Wagott's R&D and production capabilities into Layn's operations.
• Co-founders Mr. Jiang and Mr. Yao remain the company's largest individual owners and continue to exert significant strategic influence while ownership is broadly distributed among institutions and retail investors.

• Ownership structure:
  • Co-founders (collectively): majority influence and largest aggregate stake.
  • Institutional investors: significant block holdings reflecting analyst and fund interest.
  • Retail/public float: provides market liquidity and diverse shareholder mix.
  • Financial reports indicate no single shareholder holds unilateral control despite co-founders' combined majority influence.
• Corporate governance:
  • Board of directors overseeing strategy and compliance, with independent directors represented.
  • Executive management responsible for day-to-day operations, R&D prioritization, and integration of acquisitions (e.g., Wagott).

• How it works & makes money:
  • Product mix: botanical extracts, food and feed additives, specialty ingredients for nutraceutical, pharmaceutical, and food industries.
  • Revenue drivers: product sales (bulk extracts, finished formulations), proprietary R&D outputs, margins enhanced by vertical integration (post-2020 Wagott acquisition).
  • Profitability levers: scale in extraction and purification, product mix optimization toward higher-margin specialty ingredients, and export growth.

Guilin Layn Natural Ingredients Corp. (002166.SZ): Ownership Structure

• Mission and values: innovation, sustainability, respect, transparency, excellence, reliability.
• R&D and innovation: forward‑looking investment in science‑driven ingredient development and application‑oriented formulation support.
• Environmental stewardship: responsible sourcing, renewable resource management, and conservation measures across operations and supply chains.
• Ethics and governance: emphasis on integrity, authentic conduct, and transparent reporting across offices, manufacturing sites, and supplier networks.

• Vertical integration: own/controlled cultivation, extraction and downstream formulation reduces input cost, ensures quality and enables premium pricing.
• Product mix: standardized extracts (commoditized volumes) + high‑value specialty actives and tailor‑made solutions for brand customers.
• Geographic diversification: domestic China sales plus exports to Europe, Americas and Asia to capture global demand.
• Value‑added services: technical support, co‑development, regulatory assistance and supply‑chain security contracts for large customers.

Guilin Layn Natural Ingredients Corp. (002166.SZ): Mission and Values

• Seed cultivation & agronomy: proprietary cultivation protocols, supplier training and on-site seed-to-crop traceability.
• Extraction & purification: centralized extraction hubs using solvent and water-based technologies to produce stevia glycosides, monk fruit mogrosides, tea catechins and other concentrates.
• R&D & formulation: global innovation centers for product development, stability testing and sensory optimization.
• Manufacturing & packaging: finished-ingredient blending, micronization, standardization and customer-ready formats.
• Quality & compliance: in-house labs, full traceability systems and third-party certifications for food safety and sustainability.

• Stevia extracts (steviol glycosides): for beverages, tabletop sweeteners, dairy and baked goods.
• Monk fruit extract (mogrosides): zero-calorie sweetening solutions and blends with stevia.
• Tea extracts (catechins, EGCG): nutraceuticals, dietary supplements and functional beverages.
• Lovia and other botanical extracts: formulations for personal care, nutraceutical and functional-food customers.

• High-value finished ingredients: margin capture through purification, standardization and formulation services.
• Private-label and co-manufacturing: contract manufacturing for global brands and ingredient houses.
• R&D-backed product solutions: fee-based application development and customized blends for customers.
• Global distribution network: regional offices and local manufacturing shorten lead times and expand market access to food & beverage, nutraceutical and personal-care sectors.

• Listed on Shenzhen Stock Exchange: ticker 002166.SZ.
• Manufacturing hub in Guilin with global R&D and regional operations in the USA, Europe and Latin America to serve multinational customers.
• Commercial presence and exports across 80+ countries (regional distribution, technical support and local manufacturing where required).

Guilin Layn Natural Ingredients Corp. (002166.SZ): How It Works

• Primary revenue sources: sales of high-purity sweeteners (steviol glycosides, monk fruit mogrosides), functional botanical extracts, and branded ingredient systems tailored for specific applications.
• Customer segments: beverage manufacturers (zero/low-calorie drinks), confectionery, dairy, nutraceuticals, sports nutrition, animal nutrition and pet health suppliers.
• Sales channels: direct B2B contracts (long-term supply agreements), global distributors, and branded ingredient partnerships with co-developments and tolling arrangements.

• Vertical integration - control from cultivation to finished extract - reduces input cost volatility and secures supply for large customers, enabling competitive pricing and higher contract renewals.
• Branded solutions and formulation services - Layn packages ingredients into application-ready systems (e.g., sweetness blends, masking systems, stability matrices) to earn premium margins versus commodity extracts.
• R&D and product innovation - ongoing investment in next-generation sweeteners, taste-modulation technologies and low-calorie systems to meet consumer and regulatory trends.
• Diversified end-markets - revenue balance across food & beverage, nutraceuticals, sports nutrition, animal nutrition and pet health reduces cyclicality and concentration risk.

• Raw material cultivation and procurement - owned and contracted farms supplying stevia leaves, monk fruit and other botanicals lowers cost-of-goods and stabilizes quality.
• Extraction and purification - in-house extraction, chromatography and downstream processing produce high-purity actives (e.g., Rebaudioside A, Mogroside V) sold at significant per‑kg premiums.
• Formulation & branding - Layn offers application-specific blends and co-branded ingredient systems that command higher ASPs (average selling prices) and strengthen customer stickiness.
• Long-term offtake & supply agreements - multi-year contracts with food and beverage firms underpin predictable revenue and support capacity planning.

• High-purity sweeteners (stevia & monk fruit): largest single contributor, often 45-55% of total revenue depending on crop cycles and pricing.
• Botanical extracts & nutraceutical ingredients: ~20-25% of revenue, including polyphenols, plant proteins and specialty actives.
• Branded solutions and formulation services: 10-15% of revenue but higher margin, growing as Layn upsells application systems.
• Animal & pet nutrition, sports nutrition: combined 10-15%, serving as diversification engines with rising demand for natural functional ingredients.

• Scale and integration: expanding processing capacity drives fixed-cost absorption and unit cost declines.
• Product mix shift to high‑purity streams and branded systems boosts ASPs and gross margin.
• Geographic expansion and export growth increase sales to higher-margin end markets in North America, Europe and APAC.
• Co-development contracts with F&B and nutraceutical customers lock in multi-year premium pricing.

• Capacity build-out for high‑purity steviol glycosides and monk fruit extracts to meet rising global sugar-reduction demands.
• R&D focus on taste improvement, bitterness masking and glycoside fractionation to create differentiated, patentable formulations.
• Quality and regulatory compliance (GRAS, Novel Food dossiers, GMP) to facilitate entry into developed markets and premium customers.

Guilin Layn Natural Ingredients Corp. (002166.SZ): How It Makes Money

• Core product lines: high-purity stevia rebaudioside A variants, monk fruit (mogrosides), plant-based flavors and specialty extracts.
• Customer segments: ingredient formulators, branded food & beverage companies, nutraceutical manufacturers, pharmaceutical firms and personal-care producers.
• Geographic channels: domestic China sales plus growing export operations in the USA, Europe and Latin America.

• Primary revenue drivers:
  • Direct sales of bulk ingredients and high-purity sweetener isolates.
  • Private-label/OEM manufacturing and co-development agreements.
  • Export contracts and regional distributors in the USA, Europe and Latin America.
  • Value-added services: formulation support, custom extraction and licensing of proprietary processes.
• Margin levers: premium pricing for high-purity grades (steviol glycosides and mogrosides), process efficiencies from scale, and product mix shifting toward higher-margin specialty extracts.
• Investment focus: manufacturing capacity expansion, supply-chain security, and R&D to improve extraction yields and develop next-gen natural sweeteners.